http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2436589-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34243ed5d528597b57990d6901da658f |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-429 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate | 2002-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2010-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d38208b5c54fe6d12d6bd55141845d8e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d3f51b8cf0dddd9d0506f763a4b7cb4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be6ebc0c84a5286de4f5b6589b189e3e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3722b9c21756ad3743c0f090fb1073e7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_918fab5c8de6e90c8e9a527682ad3297 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2594aa76b2a45db47fb2f47046e2712e |
| publicationDate | 2010-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2436589-C |
| titleOfInvention | Heterocyclic compounds and cognitive enhancers comprising the same as effective components |
| abstract | The present invention relates to heterocyclic compound as cognitive enhancers. The heterocyclic compound may be represented by the formula I: (see formula I) wherein (see formula II) represents (see formula III), (see formula IV), (see formula V), (see formula VI), (see formula VII), (see formula VIII) or (see formula IX). In formula 1, R1 represents hydrogen atom, C1-C6 alkyl or benzyloxy; R2 represents methyl or nil; R3 represents hydrogen atom, C1-C6 alkyl, C2-C6 alkenyl, C3-C8 cycloalkyl or -CH2R5, wherein R5 represents thienyl or phenyl which may be substituted with C1-C6 alkyl, halogen atom or cyano; R4 represents C1-C6 alkyl, C2-C6 alkenyl, C3-C8 cycloalkyl or -CH2R6, wherein R6 represents naphthyl, thienyl or phenyl, which may be substituted with C1-C6 alkyl, halogen atom or cyano; or R3 is coupled with R4 into (see formula X), (see formula XI), (see formula XII) wherein R7 represents hydrogen atom, halogen atom, C1-C6 alkoxy, cyano or trifluoromethyl, (see formula XIII), cyclopentene or cyclopentane, provided that, when (see formula XIV) represents (see formula XV), R3 is a hydrogen atom or is coupled with R4 into (see formula XVI), (see formula XVII), (see formula XVIII) wherein R8 represents halogen atom, C1-C6 alkoxy, cyano or trifluoromethyl, (see formula XIX), cyclopentene or cyclopentane, where * is a point of attachment to formula (I). |
| priorityDate | 2001-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 107.